Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AMGN compared with SABS: revenue, margins and what each company keeps, and the suppliers and customers both name
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
SABS
SAB Biotherapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AMGN
Amgen Inc
vs
SABS
SAB Biotherapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
AMGN
4 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±3.7%
▲
+3.73%
×1.00
Q2 FY26
±4.1%
▲
+4.57%
×1.12
Q1 FY26
±3.9%
▼
−4.75%
×1.23
Feb 4 '26
±3.7%
▲
+8.15%
×2.22
SABS
No earnings history for SABS.
= implied
AMGN realized, solid
SABS realized, hatched
One scale, both sides: full bar = 9%
× = |realized| ÷ implied
Source: market data
AMGN
Amgen Inc
Change
460.55
▲
+0.06%
· post 460.42
Mkt cap
$249.0B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
SABS
SAB Biotherapeutics, Inc.
Change
3.02
▲
+2.59%
· post 3.02
Closed
Nov 6 '26
Mkt cap
$273.0M
Revenue
$114,698
Q4 FY24
Revenue
—
vs
Compare
Closed
Nov 6 '26
AMGN
Amgen Inc
vs
SABS
SAB Biotherapeutics, Inc.
460.55
▲
+0.06%
post 460.42
Price
3.02
▲
+2.59%
post 3.02
$249.0B
Mkt cap
$273.0M
Q3 FY26
$10.4B
Revenue
$114,698
Q4 FY24
FY25
$36.8B
Revenue
—
Change
Change
AMGN
460.55
▲
+0.06%
vs
SABS
3.02
▲
+2.59%
Closed
Nov 6 '26